Evidence map›Paper›PMID 33644680›Full record

ArticleJNCI cancer spectrum2021

Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer.

Adithya D Vellal, Korsuk Sirinukunwattan, Kevin H Kensler, Gabrielle M Baker, Andreea L Stancu, Michael E Pyle, Laura C Collins, Stuart J Schnitt, James L Connolly, Mitko Veta and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in JNCI cancer spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Early-Life and Adult Adiposity, Adult Height, and Benign Breast Tissue Composition.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Adithya D VellalDepartment of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Korsuk SirinukunwattanDepartment of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Kevin H KenslerDivision of Population Sciences, Dana Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0001-7515-7270
Gabrielle M BakerDepartment of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Andreea L StancuDepartment of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0003-2801-2620
Michael E PyleDepartment of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Laura C CollinsDepartment of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Stuart J SchnittDana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Dana-Farber Cancer Institute-Brigham and Women's Hospital, Boston, MA, USA.
James L ConnollyDepartment of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Mitko VetaMedical Image Analysis Group, Eindhoven University of Technology, Eindhoven, the Netherlands.
A Heather EliassenChanning Division of Network Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-3961-6609
Rulla M TamimiChanning Division of Network Medicine, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Yujing J HengDepartment of Pathology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Beth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USDana-Farber Cancer Institute · USEindhoven University of Technology · NL

Funding

Life Course Cancer Epidemiology Cohort in WomenU01CA176726 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI ELIASSEN, A. HEATHER, WILLETT, WALTER C. · 2018 to 2025
$22.4M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Mammographic density and texture features in relation to breast cancer riskR01CA175080 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TAMIMI, RULLA M · 2013 to 2016
$1.7M
The role of breast stem cells in breast cancer etiology and risk predictionR01CA240341 · NCI · UNIVERSITY OF FLORIDA · PI YAGHJYAN, LUSINE · 2020 to 2023
$1.4M
Computational pathology to predict breast cancer risk in benign breast diseaseR21CA187642 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCHNITT, STUART, TAMIMI, RULLA M · 2015 to 2016
$439k
NCI NIH HHS R01 CA175080NCI NIH HHS R01 CA240341NCI NIH HHS R21 CA187642NCI NIH HHS U01 CA176726NCI NIH HHS UM1 CA186107
6 · The paper itself

Abstract

Background: New biomarkers of risk may improve breast cancer (BC) risk prediction. We developed a computational pathology method to segment benign breast disease (BBD) whole slide images into epithelium, fibrous stroma, and fat. We applied our method to the BBD BC nested case-control study within the Nurses' Health Studies to assess whether computer-derived tissue composition or a morphometric signature was associated with subsequent risk of BC. Methods: Tissue segmentation and nuclei detection deep-learning networks were established and applied to 3795 whole slide images from 293 cases who developed BC and 1132 controls who did not. Percentages of each tissue region were calculated, and 615 morphometric features were extracted. Elastic net regression was used to create a BC morphometric signature. Associations between BC risk factors and age-adjusted tissue composition among controls were assessed using analysis of covariance. Unconditional logistic regression, adjusting for the matching factors, BBD histological subtypes, parity, menopausal status, and body mass index evaluated the relationship between tissue composition and BC risk. All statistical tests were 2-sided. Results: Among controls, direction of associations between BBD subtypes, parity, and number of births with breast composition varied by tissue region; select regions were associated with childhood body size, body mass index, age of menarche, and menopausal status (all Conclusions: The amount of epithelial tissue may be incorporated into risk assessment models to improve BC risk prediction.

Indexed as

Deep LearningAdultAgedAnalysis of VarianceBody Mass IndexBody SizeBreastBreast DiseasesBreast NeoplasmsCase-Control StudiesCohort StudiesElasticityFemaleHumansMenarcheMenopause

Identifiers

PMID33644680
PMCPMC7898083
OpenAlexW3130717504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.